Introduction
Inflammatory bowel disease (IBD) affects 1.5 million people in the United States. IBD is a multifactorial disease where both environmental and genetic factors are involved 1, 2 . Current treatment consists of corticosteroids, immunosuppressants, biologics, and in some cases, surgery, but no treatments are universally effective 3 . Thus, there is an urgent need to further understand the pathogenesis of IBD, in order to develop new therapeutics. One potential therapeutic approach is the detection and targeting of specific bacteria-mediated inflammation that initiates in the earlier stages of the disease and present in chronic infection. Microbial dysbiosis is one of the critical component of IBD [4] [5] [6] [7] . IBD samples contained abnormal GI microbiotas, a shift in the microbiota toward more pro-inflammatory species characterized by depletion of commensal bacteria, notably members of the phyla Firmicutes, Bacteroidetes, Bifidobacterium, Clostridia and enrichment of Actinobacteria and Gamma proteobacteria [8] [9] [10] . Adherent-invasive E. coli (AIEC) is the major pathovar of the species Escherichia coli that has isolated from CD patients 11 .
Intestinal dysbiosis triggers distinct steps at the host-microbe interface--First, recognition and internalization of pathogen by phagocytic receptor/mediator controls the downstream inflammatory responses 12, 13 . For example, AIECs must adhere and invade the gut epithelial cells, followed by engulfment to macrophages and induction of inflammatory pathways in host cells 14 .
A finite inflammatory response is essential to clear the infection without extensive collateral damage and destruction of host tissue. However, the defective clearance of bacteria is the hallmark in CD, with a resultant retention of the engulfed bacteria within macrophages propagates inflammation, creates a vicious cycle of subsequent rounds of recruitment of monocytes and T lymphocytes and the release of proinflammatory cytokines. The underlying mechanism of host epithelium, which is breached by invading pathogens and initiates responses to mount an inflammatory cytokine storm is unclear.
We recently demonstrated that Engulfment and cell motility protein 1 (ELMO1) is a microbial sensor that enables macrophages to engulf enteric bacteria, and coordinately mount inflammation while orchestrating bacterial clearance via the phagolysosomal pathway [15] [16] [17] .
ELMO1 binds the Pattern Recognition Receptor (PRR) Brain Angiogenesis Inhibitor-1 (BAI1) which recognizes bacterial Lipopolysaccharide (LPS) 18 . BAI1-ELMO1 signaling axis activates
Rac1 and induces pro-inflammatory cytokines Tumor necrosis factor-TNF-and Monocyte
Chemoattractant protein 1 (MCP-1) 15, 19 . BAI1-ELMO1 signaling axis regulates the expression of ATP-binding cassette transporter ABCA1 which is linked to the development of cardiovascular diseases (CVD) 20 . Genome wide association studies (GWAS) have revealed the association of single nucleotide polymorphisms (SNPs) in ELMO1 with IBD, rheumatoid arthritis (RA) kidney disease and diabetic nephropathy [21] [22] [23] . ELMO1 is required for the induction of several proinflammatory cytokines that are known to drive a plethora of inflammatory diseases including IBD, CVD and RA 15 . Among them, MCP-1 is a chemokine, which plays a significant role in the recruitment of mononuclear cells to the site of inflammation; it is also one of the major cytokines involved in inflammatory diseases like IBD 24 .
The function of ELMO1 in phagocytic cells is clear; however, its role in the non-phagocytic cells, i.e., the gut epithelium remains unknown. We hypothesized that the sensing of IBDassociated microbes by ELMO1 in the gut epithelium, the first line host defense, may serve as an upstream trigger for immune cell-mediated cytokine storm. We used the cutting-edge stem cell based-enteroids as the model system to interrogate the role of ELMO1 in epithelial cells faced with the dysbiosis in CD patients, and defined a specific need for the engulfment pathway in the induction of MCP-1. The generation of MCP-1 by the epithelium appears to be followed by monocyte recruitment at the site of inflammation. Subsequently, bacteria enter monocytes in an ELMO1-dependent manner and trigger the release of TNF- thereby, propagating the chronic inflammatory cascade that is the hallmark of IBD. Findings raise the possibility that targeting ELMO1 may help simultaneously blunt both the ELMO1-MCP-1 and the ELMO1-TNF-α signaling axes in the epithelium and the macrophages, respectively, to combat the inflammation in IBD.
Materials and Methods
All authors had access to the study data and reviewed and approved the final manuscript.
Bacteria and Bacterial Culture
Adherent Invasive Escherichia coli strain LF82 (AIEC-LF82), isolated from the specimens of Crohn's disease patient, was obtained from Arlette Darfeuille-Michaud 11 . A single colony was inoculated into LB broth and grown for 8 h under aerobic conditions and then under oxygenlimiting conditions. Cells were infected with a multiplicity of infection (moi) of 10.
Animal
WT and ELMO1 KO C57BL/6 mice were gender-and age-matched litter mate, that used to isolate intestinal crypts and macrophages. Animals were bred, housed, and euthanized according to all
University of California San Diego Institutional Animal Care and Use Committee (IACUC)
policies.
Human Subjects
All the IBD patients were seen at the University of California, San Diego at the IBD-Center. They were recruited and consented using a study proposal approved by the Institutional Review Board of University of California, San Diego. The clinical phenotype and information were assessed by an IBD specialist.
Cell Lines and Cell Culture
Control and ELMO1 small-hairpin RNA (shRNA) macrophage (J774) cells were maintained in high glucose Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum, as described previously 15 . THP-1 cells were maintained in RPMI media containing 10 mM HEPES, 10 % FBS at a cell concentration of lower than 10 6 cells/ml 19 .
Isolation of enteroids from colonic specimens of mouse and human
Intestinal crypts were isolated from the colonic tissue specimen by digesting with Collagenase type I [2 mg/ml; Invitrogen] and cultured in stem-cell enriched conditioned media with WNT 3a, Rspondin and Noggin [25] [26] [27] . The details are mentioned in the Supplementary Materials and Methods.
The preparation of Enteroid-derived monolayers (EDMs)
To prepare EDMs, single cells from enteroids in 5% conditioned media was added to diluted Matrigel (1:30) as done before 28 . In some cases, the EDMs were also differentiated for 2 days in advanced DMEM/F12 media without Wnt3a but with R-spondin, Noggin, B27 and N2 supplements and 10 M ROCK inhibitor 26 . As expected, this results in a marked reduction in the expression of the stemness marker Lgr5 in EDMs 26 .
Isolation of murine intestinal macrophages
Intestinal macrophages were isolated as described previously 15, 17, 18 and in the supplementary
Materials and Methods

Bacterial internalization by gentamicin protection assay
Approximately 2x10 5 cells were plated onto a 0.4 µm pore transwell insert and infected with bacteria with moi 10. Bacterial internalization was determined after 6 h of infection of WT and ELMO1-/-EDMs with AIEC-LF82 by gentamicin protection assay 15, 18 .
Monocyte Recruitment Assay
WT and ELMO1-/-EDMs were plated in the transwell for polarization, and infected with AIEC-LF82 for 6 h. Supernatant from the basolateral chamber was collected and placed in the new 24-well plate, and 6.5 mm 8-µm pore-sized transwells (Costar) where THP-1 cells or peripheral bloodderived monocytes in OptiMEM (Gibco) were placed on the apical chamber. In another assay, the EDM layer was collected and flipped and placed on the bottom of the transwell. The number of recruited live monocytes were measured after 1, 2, 8, 16 and 24 h.
Cytokine Assays
Supernatants were collected from the basolateral chamber either uninfected or after infected cells.
MCP-1 was measured using the Mouse CCL2 (MCP-1) ELISA Ready-Set-Go Kit according to manufacturer's instructions (eBioscience). Supernatants were collected from control or ELMO1-depleted J774 cells after AIEC-LF82 infection and TNF- was measured using the ELISA kit from BD bioscience.
RNA Preparation, Real-Time Reverse-Transcription Polymerase Chain Reaction
EDM layer following infection with AIEC-LF82 was collected for RNA isolation followed by quantitative RT-PCR as described in details in the Supplementary Materials and Methods.
Immunohistochemistry
A total of 8 colonic specimens of known histologic type (3 normal colorectal tissue; 3 ulcerative colitis and 2 Crohn's disease) were analyzed by IHC using anti-ELMO1 antibody (1:20, anti-rabbit antibody from Novus). Briefly, formalin-fixed, paraffin-embedded tissue sections of 4 µm thickness were cut and placed on glass slides coated with poly-L-lysine, followed by deparaffinization and hydration. Heat-induced epitope retrieval was performed using citrate buffer (pH-6) in a pressure cooker. Tissue sections were incubated with 0.3% hydrogen peroxidase for 15 min to block endogenous peroxidase activity, followed by incubation with primary antibodies for 30 min in a humidified chamber at Room temperature. Immunostaining was visualized with a labeled streptavidin-biotin using 3,3′-diaminobenzidine as a chromogen and counterstained with hematoxylin.
Gene expression analysis
The association between the levels of ELMO1 and MCP-1 (CCL2) mRNA expression was tested in a cohort of normal colon tissue as described in details in the Supplementary Materials and Methods.
Confocal Microscopy
WT and ELMO1-/-EDMs were plated onto 8-well chamber slides (Millicell) and infected with bacteria with moi 10. After infection, cells were stained for LAMP-1 (Lysosomal Associated Membrane Protein-1) and ZO1 (Zonula Occludens) following the protocols as mentioned in the Supplementary Materials and Methods.
Statistical analysis
Bacterial internalization, monocyte recruitment assays and ELISA results were expressed as the mean ± SD and compared using a two-tailed Student's t test. Results were analyzed in the Graphpad Prism and considered significant if p values were < 0.05.
Results
3.1.
Expression of ELMO1 positively correlates with that of pro-inflammatory cytokines, MCP-
and TNF-
Previously we showed that ELMO1 is involved in intestinal inflammation and microbial sensing 15 .
To understand the role of ELMO1 in IBD, we analyzed publicly available datasets [Pubmed; Gene Expression Omnibus (GEO) datasets GDS1330 / 24F24] 29 for expression of ELMO1 in the sigmoid colons of UC and CD patients ( Figure 1A ). In healthy humans, ELMO1 expression is heterogeneous with an average expression of ~0.10 Arbitrary Units (AU). In patients with CD and UC however, expression is higher in both when compared to healthy humans (with p value of 0.036).
The relative expression of pro-inflammatory cytokines TNF-α, MCP-1, and ELMO1 was assessed in RNA isolated from human biopsy samples from healthy controls or with IBD ( Figure   1B ). Compared to healthy controls, expression of both TNF-α and MCP-1 were elevated ~6-fold in patients with active CD. As for ELMO1, its expression was elevated ~4-fold compared to healthy controls.
The association between the levels of ELMO1 and MCP-1 (CCL2) was studied in the publicly available NCBI-GEO data-series where RNA Seq data from 214 normal colons showed that ELMO1 and MCP-1 genes display a Boolean relationship in which, if the levels of expression of one is high, usually the other is also high ( Figure 1C ). These findings suggest a more fundamental gene expression signature that is conserved despite population variance.
To determine if elevated ELMO1 mRNA levels translate into elevated protein expression, and if so, which cell types contribute to such elevation we performed immunohistochemistry (IHC) on colonic biopsies from healthy controls or patients with UC or CD ( Figure 2 ). We detected ELMO1 both in the epithelium and the lamina propria of the normal gut; expression was variable between individuals. In biopsies from patients with CD or UC, ELMO1 expression was elevated both in the epithelium and the lamina propria, but most strikingly in the diseased epithelium.
Taken together, these findings indicate that expression of ELMO1 is elevated in colons of patients with IBD; expression was detected not just in the lamina propria, presumably contributed by infiltrating immune cells, but also in the epithelial lining.
3.2.
The adherent-invasive E. coli (AIEC) is a model bacterium to study the role of the host engulfment pathway in CD pathogenesis.
To investigate the role of ELMO1 in the IBD-afflicted gut epithelium, we utilized the stem-cell derived 3D intestinal organoids or enteroids 30 . Enteroids mimic the in vivo situation with four different cell types' epithelial, goblet, Paneth cells and enterocytes [31] [32] [33] . Therefore, the use of human crypt-derived enteroids recreates normal intestinal physiology. We generated enteroids ( Figure 3A i) from colonic biopsies obtained from healthy controls and CD patients, and enteroidderived monolayers ( Figure 3A ii) ( Table 1 for patient demographics and clinical information).
First, we confirmed that ELMO1 is indeed expressed in the human enteroids from colon and ileum by immunoblotting ( Figure 3B ) and by quantitative real-time RT-PCR (qRT-PCR; Figure 3C ). When compared to healthy controls, levels of ELMO1 mRNA were elevated in CDderived enteroids ( Figure 3C ). Although the degree of elevation, was heterogeneous, as expected
given that the patients were receiving anti-TNF-α therapy before biopsies were taken (Table 1) , the degree of increase in ELMO1 positively tracked with markers of inflammation, i.e., expression of MCP-1 and IL-8 ( Figure 3C ).
To understand the role of epithelial ELMO1 following exposure to IBD-associated bacteria, we chose to study adherent-invasive E. coli (AIEC-LF82) as a model bacteria 11, 34, 35 .
Because invasive microbes attack the integrity of epithelial tight junctions (TJs), trigger a redistribution of apical tight junction protein Zonula Occludens-1 (ZO-1) 36 and thereby, breach the epithelial barrier function during invasion, we investigated epithelial TJs between healthy or CDderived enteroids after exposure to AIEC-LF82. TJs were clearly defined and intact in the uninfected healthy EDMs, but they were disrupted when EDMs were infected with AIEC-LF82
( Figure 2D ). In fact, the extent of disruption was almost similar (i.e., ~90-95 % area affected) to uninfected CD-derived EDMs at baseline. Upon infection, the CD-derived EDMs showed increased levels of ZO1 at the TJs, which may be due to a short-term protective mechanism(s) that recruits ZO1 to resist infection/stress-induced TJ collapse. These findings confirm that the CDassociated AIEC-LF82 can indeed disrupt epithelia TJs in the healthy epithelium, much like that seen in CD-derived EDMs at baseline, providing a solid rationale for continuing to study the interplay between the AIEC-LF82 and epithelial ELMO1.
ELMO1 is required for the engulfment of AIEC-LF82 within the gut epithelium.
Interactions of the invading microbe with the host cellular processes is a key trigger for the generation of inflammatory responses. Although phagocytic cells are primarily engaged in the uptake and clearance of microbes, it is well known that microbes do enter through epithelial TJs 37 .
What is unknown is whether the epithelial cell relies on the engulfment pathway for uptake and subsequently clear them via the phagolysosomal pathway. To understand the role of ELMO1 during bacterial entry into epithelial cells, we used EDMs generated from colons of Wild type (WT) and ELMO1 -/-mice. Depletion of ELMO1 in the EDMs from ELMO1 -/-mice was confirmed by immunoblotting ( Figure 4A ). When bacterial internalization was measured using the wellaccepted gentamicin protection assay 18, 38 , we found that compared to WT controls (n = 10), internalization at 1 h after infection was decreased by 73% decrease in ELMO1 KO EDMs (n = 8) (p < 0.05; Figure 4B ).
We also carried out confocal immunofluorescence studies to evaluate how the bacteria enter the epithelial cells. We found that in both WT and ELMO1 -/-EDMs the AIEC-LF82 enter through the epithelial TJs, as determined by ZO-1 staining that surrounded the bacteria ( Figure   4C ). However, we found dissimilarities when it comes to the proximity of lysosomes to the invading pathogens. In WT EDMs, lysosomes (as detected using the lysosomal integral membrane protein, LAMP1) were found in close proximity to the invading AIECs ( Figure 4C ) in WT EDMs, indicating that lysosomes are recruited to the site of TJ breach; such approximation was not seen in the ELMO1 -/-EDMs. These findings raise the possibility that in the absence of lysosome targeting, ELMO1 -/-EDMs may be defective not just in bacterial uptake, but also in bacterial clearance. These findings are consistent with our previously published role of ELMO1 in the clearance of another invasive pathogen, Salmonella 17 . Although typically longer time points are required to assess clearance, such assays were not possible using EDMs as model system. This is because one of the major limitations of EDMs is that when infected, they typically undergo extensive cell death within 8 -12 h, making any cellular morphological analysis technically impossible.
Taken together, our results using ELMO1 -/-EDMs demonstrate that ELMO1 is required for AIEC-LF82 uptake through breaches in the epithelial TJs, and for the proper targeting of lysosomes to the invading AIEC-LF82 pathogen. Morphologic findings in EDMs predict that once internalized, ELMO1 may also be required for efficient clearance of the AIEC-LF82 (studied in detail with macrophages in Figure 6B and Supplementary Figure 1) .
ELMO1 in the gut epithelium is required for the generation of pro-inflammatory cytokine
MCP-1 following infection with AIEC LF82.
We previously showed that ELMO1 and an intact host engulfment pathway is essential for the induction of pro-inflammatory cytokine MCP-1 in monocytes 15 . Because the inflamed gut epithelium can express MCP-1 39 , and because MCP-1 plays a major role in recruiting monocytes that in turn generates inflammatory cytokines in CD-afflicted gut [39] [40] [41] [42] , we hypothesized that ELMO1 may be required also for MCP-1 production by the gut epithelium once it is breached by invading AIEC-LF82.
We first asked if there is any correlation between ELMO1 expression and MCP-1 in CDderived EDMs. To this end, we measured the levels of MCP-1 by qRT-PCR ( Figure 5A ) and by ELISA ( Figure 5B ). In WT EDMs, MCP-1 was undetectable without infection, but its levels were elevated after infection. Compared to WT EDMs, infection-triggered induction of MCP-1 was blunted in ELMO1 -/-EDMs ( Figure 5A -B).
Taken together, these findings demonstrate that ELMO1 is required for the generation of MCP-1 by the epithelium that is breached by CD-associated invasive pathogens, and that the ELMO1-MCP-1 axis may be a fundamental pathway that responds to dysbiosis in the gut lumen.
An intact ELMO1-MCP-1 axis in the gut epithelium is required for the recruitment of monocytes to the infected epithelium
Previous studies have demonstrated that CCL2/MCP-1 -/-mice had significant reduction in monocyte recruitment in inflammatory models and Th2 cytokines (IL-4, IL-5 and IFN-γ) in the secondary pulmonary granulomata in response to Schistosoma mansoni eggs 43, 44 . To understand the role of the ELMO1-MCP-1 axis in the recruitment of monocytes, we infected the WT and ELMO1 -/-EDMs with AIEC-LF82 for 6 h and assessed the ability of these EDMs to recruit monocytes. After the infection, either the conditioned supernatant ( Figure 5C ) or the infected monolayer itself ( Figure 5D ) was co-cultured with monocytes, and migration of monocytes toward the infected EDM site was assessed. Compared to WT EDMs, ELMO1 -/-EDMs displayed a 50% reduction in monocyte recruitment. These results indicate that ELMO1-dependent MCP-1 production by the gut epithelium could serve as an upstream cue for monocyte recruitment to the sites of infection. TNF- is a major pro-inflammatory cytokine that is elevated early in the development of CD 39, 45 . Macrophages exposed to AIECs engulf the bacteria, and can induce TNF-α 39 . We analyzed how reduced engulfment in the absence of ELMO1 impacts the release of TNF- into 13 the supernatant from control and ELMO1-depleted [by shRNA] J774 macrophages that were infected with AIEC-LF82. Using ELISA to detect the cytokine, we found that, the ELMO1-depleted macrophages had significant reduction in TNF- compared to control shRNA cells (p value 0.0006; Figure 6C ). These findings are consistent with our previous findings in the context of Salmonella 15 .
ELMO1 in macrophages is
Discussion
The major finding of our work is the identification of the engulfment pathway that is coordinated by ELMO1 as a novel host response element, which operates in two different cell types in the gut, i.e., the epithelium and the monocytes. ELMO1 facilitates the engulfment of pathogenic microbes in the gut epithelium, triggers the induction of the pro-inflammatory cytokine, MCP-1; the latter helps recruit monocytes from peripheral blood to the site of local inflammation ( Figure 6D ). Our results also highlight and exemplify the complex multi-step interplay between luminal dysbiosis, which is an invariant hallmark in IBD and macrophages, key players in the innate immune system of the gut. First, we show that the pathogenic AIEC-LF82 strain that is associated with CD can invade the gut epithelial lining by entering through epithelial TJs, and subsequently triggers the production of the pro-inflammatory cytokine, MCP-1 before being cleared via the phagolysosomal pathway. In the absence of ELMO1, uptake of the bacteria into the epithelial cells is impaired, and MCP-1 production is blunted. This ELMO1-MCP-1 axis then triggers the recruitment of monocytes. Next, we showed that the same molecule, ELMO1 is also essential for the uptake and clearance of AIEC-LF82 in the monocytes, and is required for coordinately mounting yet another pro-inflammatory cytokine response, TNF-α. This ELMO1-TNF-α axis presumably feeds forward to propagate inflammation in the gut by triggering the activation of other monocytes and T cells.
Thus, the two signaling axes, ELMO1-MCP-1 and ELMO1-TNF-α, orchestrated by the same engulfment pathway in two different cell types, the epithelium and the monocytes, respectively, appear to be working as 'first' and 'second' responders to combat pathogenic microbes, thereby relaying distress signals from one cell type to another as the microbe invades through the breached mucosal barrier.
Until now, the majority of IBD-related research and therapeutic strategies have remained focused on T cell responses and on neutralizing the impact of TNF-α. By demonstrating the presence of two hierarchical spatially and temporally separated signaling axes, our work provides mechanistic insights into some of the upstream/initial immune responses that play out in the epithelium and within the macrophages upon sensing luminal dysbiosis. This 3-way interaction between microbe-epithelium-macrophages is crucial to maintain homeostasis, and intestinal macrophages maintain the balance between homeostasis and inflammation 46 . A breach in the epithelium brought about by invading pathogens shifts the balance towards pro-inflammatory pathways. This work defines an upstream event that could be exploited to develop biomarkers, and eventually interrogated for the identification of strategies for therapeutic intervention (e.g., anti-MCP-1 therapy, as discussed later). The need for an in-depth understanding of the nature and the extent of the contribution of epithelial cells and/or monocytes in disease progression is urgent because of the limited efficacy of the available treatment options 47 . Because the recruitment of monocytes from circulation to the site of infection/inflammation is a key early event in inflammatory diseases of the gut, the ELMO1→MCP-1 axis we define here is potentially an actionable high value diagnostic and therapeutic target in IBD. Detection of high levels of ELMO1
in the epithelium could serve as an early indicator of activation of the engulfment pathway, and hence, could serve as a surrogate diagnostic marker of early inflammation due to luminal dysbiosis.
Similarly, targeting the engulfment pathway is expected to restore immune homeostasis and resolve chronic inflammation via a completely novel approach that could synergize with existing therapies, and thereby, improve response rates and rates of sustained remission.
This work also provides the first mechanistic insights into how luminal dysbiosis initiates inflammation in the gut. 49 . In CD granuloma, the number of mucosal adherent invasive E. coli is higher because of defective clearance and that can cause dysbiosis 8, 50 . Previously we showed that ELMO1 and the engulfment-pathway in the professional phagocytes is essential for the internalization of Salmonella, and for mounting intestinal inflammation 15 . Lysosomes were seen in close proximity to the invading bacteria exclusively in the WT EDMs.
Right: RGB plots show distance in pixels between the internalized bacteria (blue) and the TJs of host cells (red) and lysosomes (green). 
Isolation of enteroids from colonic specimens of mouse and human
The crypts after digestion with Collagenase were filtered with a cell strainer and washed with medium (DMEM/F12 with HEPES, 10% FBS), After adding collagenase I solution containing gentamicin (50 g/ml, Life Technologies) and mixing thoroughly, the plate was incubated at 37°
C inside a CO2 incubator for 10 min, with vigorous pipetting between incubations and monitoring the intestinal crypts dislodging from tissue. The collagenase was inactivated with media and filtered using a 70-µm cell strainer over a 50-ml centrifuge tube. 
RNA Preparation, Real-Time Reverse-Transcription Polymerase Chain Reaction
RNA was prepared using RLT buffer (Qiagen Beverley, Inc) and β-mercaptoethanol. Total RNA was extracted using the RNeasy Microkit (Qiagen Beverly, Inc) and reverse transcribed with a cDNA Supermix (Qiagen Beverly, Inc), both according to the manufacturer's instructions and as done previously 2, 3 . Real-time RT PCR was performed using SYBR Green High ROX (Biotool) with primers (Intergrated DNA Technologies) detected using StepOnePlus Real-Time PCR Systems (Applied Biosystems) and normalized to the values of β-actin for mice and GAPDH for human. The fold change in mRNA expression was determined using the ΔΔCt method as done previously [2] [3] [4] .
PCR primers
Mouse CCL2 (MCP-1), KC (IL-8), and β-actin mRNA were amplified by using the primers: 
Gene expression analysis
This cohort included gene expression data from multiple publicly available NCBI-GEO data-series and CCL2), we applied the Hegemon, "hierarchical exploration of gene expression microarrays on-line" tool 5 . The Hegemon software is an upgrade of the BooleanNet software 6 , where individual gene-expression arrays, after having been plotted on a two-axis chart based on the expression levels of any two given genes, can be stratified using the StepMiner algorithm and automatically compared for statistically significant differences in expression. We stratified the patient population of the NCBI-GEO discovery dataset in different gene-expression subgroups, based on the mRNA expression levels of ELMO1. Once grouped based on their gene-expression levels, patient subsets were compared for CCL2.
Confocal Microscopy
After 1 h infection, media was aspirated, and cells were treated with 5% CM media with 250 µg/ml gentamicin for 90 min. Media was aspirated and 5% CM media was added to the wells. and 543 and transmission light, with respective detection. Z-stack acquisition was performed using a 1024x1024 pixels (58.3x58.3 micron) with a total of 10 sections (0.35 micron thickness). Images were analyzed in FIJI of ImageJ. Image flattening was obtained using average projection.
Isolation of murine intestinal macrophages
Murine intestinal macrophages were isolated using methods described previously 2, 3, 7 . Briefly, small intestines were collected and intestinal fragments were digested with enzyme cocktail including collagenase (Miltenyi Biotec). The cell suspension was passed through a cell strainer to remove debris, and enriched with CD11b + cells using the CD11b MACS kit (Miltenyi Biotec).
Intestinal macrophages were labeled using monoclonal antibody CD11b (BD Biosciences) and sorted using a FACS Vantage (BD Biosciences). The purity of intestinal macrophages were determined by staining with antibody specific for the macrophage marker F4/80. 
